Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers
Clinical trial NCT01934101 · TERMINATED
Trial details
- NCT number
- NCT01934101
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-12
- Primary completion
- 2014-05-28
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.